Oxidative damage to βL-crystallin in vitro by iron compounds formed in physiological buffers
Biophysical Chemistry · 2023
DOI: 10.1016/j.bpc.2023.106963 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biophysical Chemistry, 2023. Verfasst von Nicolay B Poliansky und 4 weiteren Autor:innen. Beteiligte Einrichtung: Emanuel Institute of Biochemical Physics of RAS, Moscow, Russia. Hauptthemen laut MEDLINE: Crystallins, Iron Compounds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Ministry of Education and Science of the Russian Federation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Emanuel Institute of Biochemical Physics of RAS, Moscow, Russia.
- Emanuel Institute of Biochemical Physics of RAS, Moscow, Russia; N.N. Semenov Federal Research Center for Chemical Physics of RAS, 119991, Kosygin Street 4, Moscow, Russia.
- Research Institute of Eye Diseases, Moscow, Russia.
- Emanuel Institute of Biochemical Physics of RAS, Moscow, Russia. Electronic address: k.muranov@sky.chph.ras.ru.
Förderung
- Ministry of Education and Science of the Russian Federation
Zitieren
APA
Poliansky, N. B., Motyakin, M. V., Kasparov, V. V., Novikov, I. A., & Muranov, K. O. (2023). Oxidative damage to βL-crystallin in vitro by iron compounds formed in physiological buffers. Biophysical Chemistry. https://doi.org/10.1016/j.bpc.2023.106963
Vancouver
Poliansky NB, Motyakin MV, Kasparov VV, Novikov IA, Muranov KO. Oxidative damage to βL-crystallin in vitro by iron compounds formed in physiological buffers. Biophysical Chemistry. 2023. doi:10.1016/j.bpc.2023.106963
BibTeX
@article{Poliansky2023,
author = {Poliansky, Nicolay B and Motyakin, Mikhail V and Kasparov, Valery V and Novikov, Ivan A and Muranov, Konstantin O},
title = {Oxidative damage to βL-crystallin in vitro by iron compounds formed in physiological buffers},
journal = {Biophysical Chemistry},
year = {2023},
doi = {10.1016/j.bpc.2023.106963}
}
EUVIMED